{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:54:34Z","timestamp":1789541674271,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016728","name":"Kyoto Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10025"],"award-info":[{"award-number":["25K10025"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25KJ2197"],"award-info":[{"award-number":["25KJ2197"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016981","name":"Pharmaceutical Society of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118664","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:44:05Z","timestamp":1776354245000},"page":"118664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of daurioxoisoporphine D and moringamine I as blood\u2013brain barrier\u2013permeable natural inhibitors of amyloid-\u03b2 aggregation and neuronal toxicity"],"prefix":"10.1016","volume":"138","author":[{"given":"Hayato","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohgita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118664_bb0005","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bmc.2026.118664_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105192","article-title":"New perspectives on the basal forebrain cholinergic system in alzheimers disease","volume":"150","author":"Berry","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bmc.2026.118664_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of alzheimers disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bmc.2026.118664_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jnc.12202","article-title":"Alzheimers a\u03b242 and a\u03b240 peptides form interlaced amyloid fibrils","volume":"126","author":"Gu","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2026.118664_bb0025","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/jacs.4c15532","article-title":"Transition-state-dependent spontaneous generation of reactive oxygen species by a\u03b2 assemblies encodes a self-regulated positive feedback loop for aggregate formation","volume":"147","author":"Chen","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118664_bb0030","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1096\/fj.201900604R","article-title":"High molecular weight amyloid \u03b21\u201342 oligomers induce neurotoxicity via plasma membrane damage","volume":"33","author":"Yasumoto","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118664_bb0035","article-title":"Therapeutic time window of disease\u2013modifying therapy for early alzheimers disease","volume":"11","author":"Nakashima","year":"2025","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.bmc.2026.118664_bb0040","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/s44319-024-00294-4","article-title":"The controversy around anti-amyloid antibodies for treating alzheimers disease: the european medical agencys ruling against the latest anti-amyloid drugs highlights the ongoing debate about their safety and efficacy","volume":"25","author":"Hunter","year":"2024","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bmc.2026.118664_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2026.118664_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/indj\/2025\/v22i3476","article-title":"Lecanemab: a targeted approach to beta amyloid reduction in alzheimers disease","volume":"22","author":"Gupta","year":"2025","journal-title":"Int Neuropsychiatr Dis J"},{"key":"10.1016\/j.bmc.2026.118664_bb0055","first-page":"030","article-title":"Lecanemab: the advent of biologicals in alzheimers disease, affordability, and clinical relevance","volume":"15","author":"Anil","year":"2024","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.bmc.2026.118664_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and regional projections of the economic burden of alzheimers disease and related dementias from 2019 to 2050: a value of statistical life approach","volume":"51","author":"Nandi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.bmc.2026.118664_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209218","article-title":"Cost-effectiveness of lecanemab for individuals with early-stage alzheimer disease","volume":"102","author":"Nguyen","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.bmc.2026.118664_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. small molecules: drug costs and patient access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.bmc.2026.118664_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","article-title":"Conserved cell types with divergent features in human versus mouse cortex","volume":"573","author":"Hodge","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118664_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46554-8","article-title":"Neuropathogenesis-on-chips for neurodegenerative diseases","volume":"15","author":"Amartumur","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118664_bb0085","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41380-025-03041-w","article-title":"Alzheimer\u2019s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery","volume":"30","author":"Ji","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bmc.2026.118664_bb0090","article-title":"A microfluidic model of AQP4 polarization dynamics and fluid transport in the healthy and inflamed human brain: the first step towards glymphatics\u2013on\u2013a\u2013chip","volume":"6","author":"Soden","year":"2022","journal-title":"Adv Biol"},{"key":"10.1016\/j.bmc.2026.118664_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1248\/bpb.b22-00797","article-title":"Plantainoside b in bacopa monniera binds to a\u03b2 aggregates attenuating neuronal damage and memory deficits induced by a\u03b2","volume":"46","author":"Fukuda","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmc.2026.118664_bb0100","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.bmcl.2015.07.014","article-title":"Cheminformatic comparison of approved drugs from natural product versus synthetic origins","volume":"25","author":"Stratton","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118664_bb0105","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bmc.2011.01.021","article-title":"\u2018Click peptide\u2019 using production of monomer a\u03b2 from the o-acyl isopeptide: application to assay system of aggregation inhibitors and cellular cytotoxicity","volume":"19","author":"Sohma","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118664_bb0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cbic.200800765","article-title":"\u201cClick peptide\u201d: pH\u2013triggered in situ production and aggregation of monomer a\u03b21\u201342","volume":"10","author":"Taniguchi","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2026.118664_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. In: Amini s, white MK, eds","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmc.2026.118664_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/acs.chemrestox.3c00339","article-title":"Cell via cell viability assay changes cellular metabolic characteristics by intervening with glycolysis and pentose phosphate pathway","volume":"37","author":"Fan","year":"2024","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmc.2026.118664_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.974890","article-title":"More than a marker: potential pathogenic functions of MAP2","volume":"15","author":"DeGiosio","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmc.2026.118664_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxlet.2008.10.006","article-title":"Discriminative cytotoxicity assessment based on various cellular damages","volume":"184","author":"Kim","year":"2009","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bmc.2026.118664_bb0135","doi-asserted-by":"crossref","first-page":"21497","DOI":"10.1021\/acsomega.0c02063","article-title":"Distinguishing the effect on the rate and yield of a\u03b242 aggregation by green tea polyphenol EGCG","volume":"5","author":"Park","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118664_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2015","journal-title":"Nutr J"},{"key":"10.1016\/j.bmc.2026.118664_bb0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118664_bb0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118664_bb0155","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood\u2013brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118664_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091484","article-title":"Characterization of a primate blood\u2013brain barrier co-culture model prepared from primary brain endothelial cells, pericytes and astrocytes","volume":"13","author":"Watanabe","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmc.2026.118664_bb0165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1681.1994.tb02551.x","article-title":"Inhibitory effects of verapamil on [3H]\u2013acetylcholine release in the central nervous system of Sprague\u2013Dawley rats","volume":"21","author":"Tsuda","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bmc.2026.118664_bb0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1211\/jpp.62.04.0001","article-title":"Loperamide and p-glycoprotein inhibition: assessment of the clinical relevance","volume":"62","author":"Vandenbossche","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bmc.2026.118664_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bmc.2026.118664_bb0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1021\/np000532t","article-title":"Cytotoxic oxoisoaporphine alkaloids from menispermum dauricum","volume":"64","author":"Yu","year":"2001","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2026.118664_bb0185","first-page":"226","article-title":"Cytotoxic activities of alkaloid constituents from the climbing stems and rhizomes of sinomenium acutum against cancer stem cells","volume":"87","author":"Okayama","year":"2024","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2026.118664_bb0190","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/cmdc.201800196","article-title":"Oxoisoaporphine alkaloids: prospective anti\u2013Alzheimers disease, anticancer, and antidepressant agents","volume":"13","author":"Zhang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118664_bb0195","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ejmech.2009.01.021","article-title":"Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase\/butyrylcholinesterase","volume":"44","author":"Tang","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118664_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11030-018-9905-5","article-title":"Hybrids of oxoisoaporphine\u2013tetrahydroisoquinoline: novel multi-target inhibitors of inflammation and amyloid-\u03b2 aggregation in alzheimers disease","volume":"23","author":"Chen","year":"2019","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2026.118664_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuint.2017.03.007","article-title":"Oxoisoaporphine alkaloid derivative 8\u20131 reduces a\u03b21\u201342 secretion and toxicity in human cell and caenorhabditis elegans models of alzheimers disease","volume":"108","author":"Huang","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bmc.2026.118664_bb0210","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1007\/s00216-015-8704-4","article-title":"Rapid determination of eight oxoisoaporphine alkaloids in rhizoma menispermi by the optimal homogenate extraction followed by UPLC\u2013MS\/MS","volume":"407","author":"Wei","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmc.2026.118664_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.106263","article-title":"Chemical structures of polyketides and alkaloids isolated from a culture of fungus curvularia moringae","volume":"179","author":"Matsumoto","year":"2024","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2026.118664_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031592","article-title":"Nrf2-activating natural compounds in neurodegenerative diseases: targeting oxidative stress and protein aggregation","volume":"27","author":"Chico","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118664_bb0225","first-page":"1","article-title":"PI3K\/Akt pathway contributes to neurovascular unit protection of xiao-Xu-Ming decoction against focal cerebral ischemia and reperfusion injury in rats","volume":"2013","author":"Lan","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bmc.2026.118664_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/srep03594","article-title":"A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells","volume":"4","author":"Nakagawa","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118664_bb0235","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bmc.1552","article-title":"A rapid and sensitive LC\u2013MS\/MS method for quantification of donepezil and its active metabolite, 6\u2013O\u2013desmethyl donepezil in human plasma and its pharmacokinetic application","volume":"25","author":"Pilli","year":"2011","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.bmc.2026.118664_bb0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jfda.2013.05.012","article-title":"Development and validation of a UPLC\u2013DAD\u2013MS method for characterization and quantification of alkaloids in menispermi rhizoma and its preparations","volume":"21","author":"Liu","year":"2013","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.bmc.2026.118664_bb0245","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1039\/D2AN01185A","article-title":"A deep clustering-based mass spectral data visualization strategy for anti-renal fibrotic lead compound identification from natural products","volume":"147","author":"Lai","year":"2022","journal-title":"Analyst"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:44:37Z","timestamp":1780101877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0968089626001203"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118664","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of daurioxoisoporphine D and moringamine I as blood\u2013brain barrier\u2013permeable natural inhibitors of amyloid-\u03b2 aggregation and neuronal toxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118664"}}